(Q37631957)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

review article

1 reference

title

Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

1 reference

1 reference

Pierre-Olivier Fernagut

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

Maria Cruz Rodriguez Oroz

12 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Erwan Bezard

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

7

Jorge L Juncos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Valerie Voon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jeff Wickens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Christelle Baunez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Nancy Pavon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

José A Obeso

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

1140-1149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

The progression of pathology in longitudinally followed patients with Parkinson's disease.

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Levodopa-induced dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Prevalence of pathological gambling in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Problematic gambling on dopamine agonists: Not such a rarity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Association of dopamine agonist use with impulse control disorders in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Predictors of punding in Parkinson's disease: results from a questionnaire survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Punding prevalence in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Prospective prevalence of pathologic gambling and medication association in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Non-substance and substance addictions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Development of dyskinesias in a 5-year trial of ropinirole andL-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Plasma levels of rotigotine and the reversal of motor deficits in MPTP-treated primates.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Internet gambling and other pathological gambling in Parkinson's disease: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Predictors of impulsivity and reward seeking behavior with dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Estimated Prevalence of Compulsive Buying Behavior in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Psychotic and compulsive symptoms in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Localization of monoamines in the lower brain stem.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Striatonigrostriatal Pathways in Primates Form an Ascending Spiral from the Shell to the Dorsolateral Striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

5-hydroxydopamine-labeled dopaminergic axons: three-dimensional reconstructions of axons, synapses and postsynaptic targets in rat neostriatum.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Altered vesicular dopamine storage in Parkinson's disease: a premature demise

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Rapid regulation of the dopamine transporter: role in stimulant addiction?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Heterogeneous dopamine neurochemistry in the striatum: the fountain-drain matrix.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

The emergence of the volume transmission concept1Published on the World Wide Web on 12 January 1998.1

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Molecular mechanisms of L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Compulsive drug use linked to sensitized ventral striatal dopamine transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Punding and dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Targeting Ras/ERK signaling in the striatum: will it help?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Role of ERK in cocaine addiction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Personality, addiction, dopamine: insights from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Disturbance of sequential movements in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Movement preparation in Parkinson's disease. The use of advance information.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Behaviorally contingent property of movement-related activity of the primate putamen.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Interruption of a basal ganglia-forebrain circuit prevents plasticity of learned vocalizations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Birdsong and human speech: common themes and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Motor sequence learning and movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Learning and memory functions of the Basal Ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Multiple parallel memory systems in the brain of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Motivational control after extended instrumental training

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Effects of caudate nuclei or frontal cortical ablations in kittens: motor activity and visual discrimination performance in neonatal and juvenile kittens

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Effects of caudate nuclei or frontal cortex ablations in cats. IV. Bar pressing, maze learning, and performance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Inactivation of dorsolateral striatum enhances sensitivity to changes in the action-outcome contingency in instrumental conditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Impaired incentive learning in treated Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Influence of reward expectation on behavior-related neuronal activity in primate striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

A neural correlate of response bias in monkey caudate nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Neuronal activity in monkey ventral striatum related to the expectation of reward

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Changes in activity of the striatum during formation of a motor habit.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

A cellular mechanism of reward-related learning.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

A triple dissociation of memory systems: hippocampus, amygdala, and dorsal striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970287-X

7 January 2021

10.1016/S1474-4422(09)70287-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19909912%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference